Literature DB >> 18048689

5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops.

Subba Rao Nallagatla1, Jungwook Hwang, Rebecca Toroney, Xiaofeng Zheng, Craig E Cameron, Philip C Bevilacqua.   

Abstract

Molecular patterns in pathogenic RNAs can be recognized by the innate immune system, and a component of this response is the interferon-induced enzyme RNA-activated protein kinase (PKR). The major activators of PKR have been proposed to be long double-stranded RNAs. We report that RNAs with very limited secondary structures activate PKR in a 5'-triphosphate-dependent fashion in vitro and in vivo. Activation of PKR by 5'-triphosphate RNA is independent of RIG-I and is enhanced by treatment with type 1 interferon (IFN-alpha). Surveillance of molecular features at the 5' end of transcripts by PKR presents a means of allowing pathogenic RNA to be distinguished from self-RNA. The evidence presented here suggests that this form of RNA-based discrimination may be a critical step in mounting an early immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048689     DOI: 10.1126/science.1147347

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  133 in total

1.  Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Authors:  Kwanbok Lee; Nawapol Kunkeaw; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Gum-Yong Kang; Joo Young Bang; Hyung Soon Park; Chanvit Leelayuwat; Yong Sun Lee
Journal:  RNA       Date:  2011-04-25       Impact factor: 4.942

2.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents.

Authors:  Marta Olejniczak; Paulina Galka-Marciniak; Katarzyna Polak; Andrzej Fligier; Wlodzimierz J Krzyzosiak
Journal:  RNA       Date:  2012-03-12       Impact factor: 4.942

3.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

5.  Structure and function of LGP2, a DEX(D/H) helicase that regulates the innate immunity response.

Authors:  Ayaluru Murali; Xiaojun Li; C T Ranjith-Kumar; Kanchan Bhardwaj; Andreas Holzenburg; Pingwei Li; C Cheng Kao
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

6.  Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.

Authors:  Subba Rao Nallagatla; Philip C Bevilacqua
Journal:  RNA       Date:  2008-04-21       Impact factor: 4.942

7.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

8.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

9.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

10.  The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection.

Authors:  Anand Ramanathan; Swapnil C Devarkar; Fuguo Jiang; Matthew T Miller; Abdul G Khan; Joseph Marcotrigiano; Smita S Patel
Journal:  Nucleic Acids Res       Date:  2015-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.